Ronald M Kim

This inventor holds 28 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 15 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck Sharp + Dohme Corp., Merck + Co., Inc., Princeton University. Active years: 1999-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ronald M Kim. Retrieved from https://idiyas.com/inventor/ronald-m-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 28 (Patent Applications = 9)

% Patents Active = 92.9

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 15 (Patent Applications = 16)

Average Co-Inventor Count = 4.9

ph-index = 8

Forward Citations = 236(Granted Patents)

Location History:

Monmouth Junction, NJ (US) (1999 - 2000)
Hoboken, NJ (US) (2002 - 2005)
Summit, NJ (US) (2007 - 2024)

Company Filing History:

19 out of 2,405

Merck Sharp + Dohme Corp.

Merck Sharp + Dohme B.v.

patents

where one patent can have more than one assignee

Years Active: 1999-2025

Loading Chart...

Areas of Expertise:

Voltage-Gated Sodium Channels

HIV Integrase Inhibitors

Orexin Receptor Antagonists

BTK Inhibitors

Soluble Guanylate Cyclase Activators

Glucagon Receptor Antagonists

Glycopeptide Antibacterial Compounds

Combinatorial Synthesis

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12246008 - 4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels (2025-03-11),

2. 11884683 - Tricyclic heterocycle compounds useful as HIV integrase inhibitors (2024-01-30),

3. 10968210 - Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels (2021-04-06),

4. 10519147 - Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels (2019-12-31),

5. 10221167 - Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channels (2019-03-05),

6. 10011595 - Ethyldiamine orexin receptor antagonists (2018-07-03),

7. 9938276 - 6,5-bicyclic octahydropyrrolopyridine orexin receptor antagonists (2018-04-10),

8. 9834554 - BTK inhibitors (2017-12-05),

9. 9718828 - BTK Inhibitors (2017-08-01),

10. 9637486 - Btk inhibitors (2017-05-02),

11. 9481682 - Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitors (2016-11-01),

12. 9446130 - BTK inhibitors (2016-09-20),

13. 8895583 - Soluble guanylate cyclase activators (2014-11-25),

14. 8507512 - Soluble guanylate cyclase activators (2013-08-13),

15. 8455638 - Soluble guanylate cyclase activators (2013-06-04),

Title: The Inventor Ronald M Kim: Pioneering Innovations in Summit, NJ

Introduction: Ronald M Kim is a distinguished inventor based in Summit, NJ, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Ronald M Kim's latest patents include cutting-edge technologies in the fields of renewable energy, artificial intelligence, and healthcare, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Ronald M Kim has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing solutions that push the boundaries of what is possible.

Collaborations: Throughout his career, Ronald M Kim has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life, fostering a culture of innovation and excellence in the industry.

Conclusion: Ronald M Kim's passion for innovation, coupled with his relentless drive to make a positive impact on society, solidifies his position as a trailblazing inventor whose work continues to inspire and shape the future of technology.

Profile summary based on public USPTO records.